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http://dx.doi.org/10.1016/j.bgm.201
2214-0247/Copyright ª 2015, TaiwanAbstract This study aimed to investigate whether an extract of green tea (GT) modulates the
apoptotic, superoxide-dismutase (SOD), and endothelial-nitric-oxide-synthase (eNOS) levels in
rats treated with depot medroxyprogesterone acetate (DMPA). Twenty-five female Wistar rats
were divided into the following groups (nZ 5 rats each): control group, received DMPA, DMPA
plus GT extract at doses of 10.8 mg/day (DMPAþ GT1), DMPA plus DMPA plus GT extract at doses
of 21.6 mg/day (DMPA þ GT2), and DMPA plus DMPA plus GT extract at doses of 43.2 mg/day
(DMPA þ GT3). The treatment with DMPA plus GT was performed for 4 weeks. The ovarian and
endometrial apoptotic indiceswere significantly higher in the DMPA group comparedwith the un-
treated control group (p< 0.05). This increase was significantly (p< 0.05) attenuated by all dose
treatments of DMPA plus GT. The DMPA significantly decreased the SOD (ovarian) and eNOS
(endometrial) levels compared with the untreated group. The decrease in the SOD level was
significantly attenuated by highest doses of the extract. The decrease in the eNOS expression
was significantly attenuated by two highest doses of the extract. In conclusion, DMPA induces
apoptosis of the ovary and endometrium. The GT extract prohibits the increase in ovarianaster Study Programme, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, East Java,
gmail.com (N. Veri).
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106 N. Veri et al.apoptosis, at least in part by modulation of the SOD. In the endometrium, this effect may be due
to the modulation of the eNOS expression. Therefore, this may provide a natural therapy for
attenuating the ovaries and endometrial dysfunction found in DMPA users.
Copyright ª 2015, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Depot medroxyprogesterone acetate (DMPA) is an inject-
able form of progestin. Hormonal contraception is most
often used by women in the United States and in developing
countries, including Indonesia. As a routine contraceptive,
its effectiveness lasts approximately 90 days, with a preg-
nancy rate of less than 1%. Besides being used for contra-
ception, the drug is also used in cancer therapy.1e4
Folliculogenesis in the ovary can be affected by xeno-
biotics. Xenobiotics can trigger a loss of oogonia, oocytes,
and somatic cells, and a significant decrease in the number
of follicles.5 Xenobiotic compounds that can trigger oxida-
tive stress can also be toxic to the ovaries.6 The whole
morphological alteration in the ovary after DMPA therapy
appeared to be the atresia of the follicular apparatus with
degeneration of the growing follicles.7 In addition to the
ovary, the endometrium is a tissue that can be affected by
xenobiotics. Xenobiotics affect the conception, implanta-
tion, early gestation, and development of the placenta,
which are the determinants of the success of fertility and
pregnancy.8 The uterine histology reflected that the
endometrial tissue gradually became inactive, and with
prolonged treatment at high doses, atrophy of the endo-
metrium was noted.7
The process of cell death can occur in several ways,
such as necrosis, apoptosis (type-1 programmed cell
death), and autophagy (type-2 programmed cell death).9
The apoptotic pathway is induced by intracellular pro-
gram regulation, wherein dead cells activate enzymes to
degrade DNA in the nucleus and cytoplasmic protein in
the cell itself.10 Green-tea (GT) extracts primarily contain
catechins (monomeric flavonoids) (w70%), minor flavanols
(mainly quercetin, kaempferol, myricetin, and their gly-
cosides) (w10%), and polymeric flavonoids (w20%).11
Inhibiting the activation of the redox-sensitive transcrip-
tion factors, like nuclear factor kappa-light-chain
enhancer of activated B cells and activator protein 1, is
an essential mechanism of the antioxidant function of GT
catechins.12,13 This pathway may be also involved in the
antiapoptosis mechanism of GT. To the best of our
knowledge, no report has evaluated the effect of DMPA
on oxidative stress and apoptosis in the ovary and
endometrium. Accordingly, we investigated the effect of
DMPA treatment on the changes of superoxide dismutase
(SOD), endothelial-nitric-oxide-synthase (eNOS) expres-
sion, and apoptosis in the ovary and endometrium. In
addition, we also measured the change of apoptotic,
SOD, and eNOS levels in rats that received DMPA treat-
ment treated with the GT extract.Materials and methods
Animals
Twenty-five female Wistar rats, weighing 100e125 g, pur-
chased from the Physiology Laboratory, Faculty of Medi-
cine, Brawijaya University, East Java, Indonesia, were
housed in an air-conditioned room at 25  1C and 65e70%
relative humidity with a 12-hour lightedark cycle. These
animals were divided into the following groups (n Z 5 rats
each): control group, received DMPA, DMPA plus GT extract
at doses of 10.8 mg/day (DMPA þ GT1), DMPA plus GT
extract at doses of 21.6 mg/day (DMPA þ GT2), and DMPA
plus GT extract at doses of 43.2 mg/day (DMPA þ GT3). The
treatment with GT was performed for 4 weeks. The pro-
tocol used in this study was approved by the ethics com-
mittee for animal experimentation of the Brawijaya
University. Diets were made following the American Insti-
tute of Nutrition recommendations. The animals were
given food and water ad libitum during the experimental
period.GT extraction
GT was harvested from the Wonosari tea plantation,
Lawang, Malang, East Java, Indonesia. The preparation
and extraction of the GT were performed according to the
method with modification.14 The cleaned GT was then
dried at 40C in a dark room for 3 days, and grounded into
fine powder using a miller. The powder was stored at
20C in airtight containers wrapped with aluminum foil.
Then, the powder (200 g) was mechanically stirred with
1000 mL of 96% (v/v) ethanol at room temperature for 48
hours, and filtered. Subsequently, the extract was then
filtered and concentrated under negative pressure at 40C
and 70C for 1 hour, respectively. The extract was oven
dried at 40C overnight to produce powdered extracts,
and then stored at 20C in airtight containers until
application.DMPA treatment
DMPA (Depo Progestin) was injected every single week for 4
weeks at a dose of 2.7 mg/rat; it was diluted with 0.2 mL of
saline, and injected intramuscularly. The DMPA dose was
calculated according to a previous genotoxicity study in
rats.15
Protective effect of green tea 107SOD analysis
The EnzyChrom superoxide dismutase assay kit (catalog
number: EGPX008) was purchased from BioAssay Systems
(Hayward, CA, USA). The analysis was done according to the
detailed procedures in the kit.
Immunofluorescence-labeling staining of eNOS
The immunofluorescence-labeling staining of eNOS was
performed according previous study.16 Paraffin-embedded
endometrium sections (10 mm thick) were immunostained
according to the manufacturer’s instructions (Santa Cruz
Biotechnology, Dallas, TX, USA). Briefly, the ovarian sec-
tions were deparaffinized in xylene and dehydrated through
a graded ethanol series. The nonspecific protein binding
was blocked with 2% skim-milk powder in phosphate-
buffered saline (PBS) at room temperature for 20 mi-
nutes, followed by washing with PBS. Next, the ovarian
sections were incubated with rabbit anti-eNOS polyclonal
antibody (Santa Cruz Biotechnology) at specified dilutions
for 1 hour, followed by washing with PBS. The primary
antibody bindings were then detected with fluorescent-
labeled fluorescein isothiocyanate donkey antirabbit
immunoglobulin G at specified dilutions for 1 hour in the
dark, followed by washing with PBS. The expressions of
eNOS were analyzed by counting the fluorescent intensity
of cells (in arbitrary units) in five random high-power
(400) microscope fields. The fluorescent images were
recorded under a confocal laser scanning microscope
(Olympus, Tokyo, Japan). The analysis of ovarian and
endometrial apoptosis was performed with a similar
technique.
Immunofluorescence-labeling staining of apoptosis
The immunofluorescence-labeling staining of apoptosis was
performed using fluorescein-isothiocyanate Annexin V
Apoptosis Detection Kit with PI (640914; BioLegend, San
Diego, CA, USA). The analysis was done according to the
detailed procedures in the kit. The expressions of apoptotic
cells were analyzed by counting the green fluorescent of
membrane cells (apoptotic cells) compared with the red
stained cells (necrotic cells) in five random high-power
(400) microscope fields. The fluorescent images were
recorded under a confocal laser scanning microscope
(Olympus).
Ethics
This research has been approved by the research ethics
committee of the Faculty of Medicine, Brawijaya Univer-
sity, Malang, Indonesia.
Statistical analysis
Data are presented as mean  standard deviation, and
differences between groups were analyzed using one-way
analysis of variance (ANOVA) with SPSS 15.0 statistical
package (IBM, New York, USA). The post hoc test was used ifthe analysis of variance was significant. A p value < 0.05
was considered statistically significant.Results
Table 1 presents the SOD levels in the ovary from each
experimental group. The level of SOD was significantly
lower in the DMPA group compared with the untreated
control group (p < 0.05). Out of the 10.8 mg/day, 21.6 mg/
day, and 43.2 mg/day doses of GT extract, only the highest
dose significantly prevented the DMPA-induced decrease in
the SOD level in the ovary.
Table 1 presents the apoptotic index in the ovary from
each experimental group. The level of apoptotic index was
significantly higher in the DMPA group compared with the
untreated control group (p < 0.05). Out of the 10.8 mg/day,
21.6 mg/day, and 43.2 mg/day doses of GT extract, only the
highest achieved the apoptotic-index level similar to the
untreated group (p > 0.05). The first and second doses of
the extract significantly prevented the DMPA-induced in-
crease in the apoptotic-index level, but cannot reach the
level in the control group. Indeed, there was no significant
difference between the effects of these two highest doses.
Table 2 and Figure 1 present the eNOS levels in the nu-
cleus and cytoplasmic of endometrium from each experi-
mental group. The nuclear and cytoplasmic eNOS levels
were significantly lower in the DMPA group compared with
the untreated group. These decreased levels of the nuclear
and cytoplasmic eNOS in the DMPA group were significantly
increased by the administration of two highest doses of the
GT extract, to reach similar level with the untreated group.
There was no significant difference between the effects of
these two highest doses.
Table 3 presents the apoptotic index in the endometrium
from each experimental group. The level of apoptotic index
was significantly higher in the DMPA group compared with
the untreated control group (p < 0.05). All doses of the GT
extract significantly prevented DMPA-induced increase in
apoptotic index levels to reach the level in the control
group. There was no significant difference between the
effects of these doses.Discussion
Previous studies showed that DMPA acts by inhibiting
ovulation marked by low levels of the follicle-stimulating
hormone and luteinizing hormone.17,18 Plasma estradiol is
also significantly suppressed in the early follicular-phase
range, and progesterone remains very low for months.17
In this study, the level of SOD was significantly lower in
the DMPA group compared with the untreated control group
(p < 0.05). This finding indicates that DMPA increases the
superoxide-radical formation in the ovary. SODs detoxify
these superoxide radicals. This detoxification by SOD in-
duces the decrease in the level of the enzymes. The highest
dose significantly prevented the DMPA-induced decrease in
the SOD level in the ovary. Our study confirmed the results
of previous studies that GT can upregulate antioxidant en-
zymes, such as SOD, via the nuclear factor E2-related pro-
tein 2eantioxidant response element signaling.19
Table 1 Levels of SOD and apoptotic index in rat ovaries that received DMPA treatment with or without treatment with GT
extract.
Control DMPA + GT extract at several doses
0 mg/d 10.8 mg/d 21.6 mg/d 43.2 mg/d
SOD (ng/dL) 3.05  0.77 0.34  0.14* 1.05  0.38 2.16  0.32 5.18  3.57*,**,***,****
Apoptotic index (%) 5.24  1.89 36.62  10.02* 18.21  5.43*,** 12.89  1.49*,** 5.71  1.65**,***,****
Note. Values are presented as mean  standard deviation.
*p < 0.05 in comparison with the control group.
**p < 0.05 in comparison with rats that received DMPA.
***p < 0.05 in comparison with first dose of GT extract (10.8 mg/day).
****p < 0.05 in comparison with second dose of GT extract (21.6 mg/day).
DMPA Z depot medroxyprogesterone acetate; GT Z green tea; SOD Z superoxide dismutase.
Table 2 The eNOS expression in rat endometrium that received DMPA treatment with or without treatment with GT extract.
eNOS Control DMPA þ GT extract at several doses
0 mg/d 10.8 mg/d 21.6 mg/d 43.2 mg/d
Nuclear (cells) 34.40  12.30 4.40  3.97* 18.20  7.89 25.20  15.32** 34.40  13.97**
Cytoplasmic (%) 20.93  5.31 9.26  3.93* 32.10  8.48** 35.76  7.92*,** 41.96  14.11*,**
Note. Values are presented as mean  standard deviation.
*p < 0.05 in comparison with the control group.
**p < 0.05 in comparison with rats that received DMPA.
DMPA Z depot medroxyprogesterone acetate; eNOS Z endothelial nitric oxide synthase; GT Z green tea.
Figure 1 Representative micrographs of endothelial-nitric-oxide-synthase (eNOS) expression (green) as caused by depot-
medroxyprogesterone-acetate (DMPA) treatment with or without green tea (GT) at different doses: (A) control group; (B) received
DMPA; (C) DMPA plus GTextract at doses of 10.8mg/day; (D) DMPA plus GTextract at doses of 21.6mg/day; and (E) DMPA plus GTextract
at doses of 43.2 mg/day. Fluorescein-isothiocyanate staining at a magnification of 400 using confocal laser scanning microscopy.
Table 3 Apoptotic index in rat endometrium that received DMPA treatment with or without treatment with GT extract.
Control DMPA þ GT extract at several doses
0 mg/d 10.8 mg/d 21.6 mg/d 43.2 mg/d
Apoptotic index (%) 13.67  5.33 28.13  4.43* 19.58  5.31** 15.38  10.75** 13.55  2.53**
Note. Values are presented as mean  standard deviation.
*p < 0.05 in comparison with the control group.
**p < 0.05 in comparison with rats that received DMPA.
DMPA Z depot medroxyprogesterone acetate; GT Z green tea.
108 N. Veri et al.Previous studies have shown that DMPA induces the
antiproliferative and proapoptotic effect of endometrial
tissue (nonhuman primates, women) and endometrial cell
lines.20e23 Our study showed that the level of apoptotic
index was significantly higher in the DMPA group compared
with the untreated control group (p < 0.05). This findingshowed that DMPA increases apoptosis not only in the ovary,
but also in the endometrium. Our finding extended the
results of a previous study on how DMPA affects the endo-
metrium, making it thinner and atrophic.24 We hypothe-
sized that this apoptotic effect may be due, at least in part,
to the inhibition of the eNOS expression. Our data showed
Protective effect of green tea 109that the nuclear and cytoplasmic eNOS levels were signifi-
cantly lower in the DMPA group compared with the un-
treated group. Previous studies showed that nitric oxide has
a differential regulatory function of endometrial cell sur-
vival, characterized by stromal cell proliferation.25 Our
study showed that GT (two highest doses) modulates eNOS
expression and inhibits the endometrial apoptosis. This
finding confirmed the results of previous studies showing
that GT obviously inhibited hepatocellular apoptosis and
upregulated B-cell lymphoma 2 protein expression.26 Be-
sides, GT able to inhibited the changes in condensed nu-
clear and apoptotic bodies.27 Epigallocatechin gallate has
endothelium-dependent vasodilator actions mediated by
intracellular signaling pathways that lead to the activation
of eNOS.28
In conclusion, DMPA induces apoptosis of the ovary and
endometrium. The GT extract prohibits the increase in
ovarian apoptosis, at least in part by modulation of the
SOD. In the endometrium, this effect may be due to the
modulation of the eNOS expression. Therefore, this may
provide a natural therapy for attenuating the ovarian and
endometrial dysfunction found in DMPA users.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Acknowledgements
The authors gratefully acknowledge the Laboratory of
Physiology, Faculty of Medicine, Brawijaya University,
Malang for valuable technical assistance.
References
1. Erkkola R, Landgren BM. Role of progestins in contraception.
Acta Obstet Gynecol Scand. 2005;84:207e216.
2. Kaunitz AM. Injectable contraception. New and existing op-
tions. Obstet Gynecol Clin North Am. 2000;27:741e780.
3. Jain J, Dutton C, Nicosia A, et al. Pharmacokinetics, ovulation
suppression and return to ovulation following a lower dose
subcutaneous formulation of Depo-Provera. Contraception.
2004;70:11e18.
4. Toh YC, Jain J, Rahnny MH, et al. Suppression of ovulation by a
new subcutaneous depot medroxyprogesterone acetate (104
mg/0.65 mL) contraceptive formulation in Asian women. Clin
Ther. 2004;26:1845e1854.
5. Regan KS, Cline JM, Creasy D, et al. Ovarian follicular counting
in the assessment of rodent reproductive toxicity. Toxicol
Pathol. 2005;33:409e412.
6. Mingels MJJ, Geels YP, Pijnenborg JMA, et al. Histopathologic
assessment of the entire endometrium in asymptomatic
women. Hum Pathol. 2013;44:2293e2301.
7. Bhowmik T, Mukherjea M. Histological changes in the ovary and
uterus of rat after injectable contraceptive therapy. Contra-
ception. 1988;37:529e538.
8. Agarwal A, Mellado AA, Premkumar BJ, et al. The effects of
oxidative stress on female reproduction: a review. Reprod Biol
Endocrinol. 2012;10:49.
9. Yasuhara S, Asai A, Sahani ND, et al. Mitochondria, endo-
plasmic reticulum, and alternative pathways of cell death in
critical illness. Crit Care Med. 2007;35:488e495.10. Kumar V, Abbas AK, Fausto N, et al. Robins and Cotran: Path-
ologic Basis of Disease. 8th ed. Philadelphia: Saunders; 2010:
800e810.
11. Kurahashi N, Sasazuki S, Iwasaki M, et al. Green tea con-
sumption and prostate cancer risk in Japanese men: a pro-
spective study. Am J Epidemiol. 2008;167:71e77.
12. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of
the NF-kB pathway in the treatment of inflammation and
cancer. J Clin Invest. 2001;107:135e142.
13. Dong Z, Ma WY, Huang C, et al. Inhibition of tumor promoter-
induced activator protein 1 activation and cell trans-
formation by tea polyphenols, (e)-epigallocatechin gallate,
and theaflavins. Cancer Res. 1997;57:4414e4419.
14. Fard SG, Shamsabadi FT, Ernadi M, et al. Ethanolic extract of
Eucheuma cottonii promotes in vivo hair growth and wound
healing. J Anim Vet Adv. 2011;10:601e605.
15. Bakry S, Aseem N, Montaser N. Cytotoxicity and genotoxicity of
DMPA on female rats. Toxicol Lett. 2010;196:S156eS157.
16. Kania N, Mayangsari E, Setiawan B, et al. The effects of
Eucheuma cottonii on signaling pathway inducing mucin syn-
thesis in rat lungs chronically exposed to particulate matter 10
(PM10) coal dust. J Toxicol. 2013;2013:8. Article ID 528146.
http://dx.doi.org/10.1155/2013/528146.
17. Mishell Jr DR, Kletzky OA, Brenner PF, et al. The effect of
contraceptive steroids on hypothalamicepituitary function.
Am J Obstet Gynecol. 1977;128:60e74.
18. Jeppson S, Gershagen S, Johansson EDB, et al. Plasma levels of
medroxyprogesterone acetate (MPA), sex-hormone binding
globulin, gonadal steroids, gonadotrophins and prolactin in
women during long-term use of depo-MPA (Depo-Provera) as a
contraceptive agent. Acta Endocrinol (Copenh). 1982;99:
339e343.
19. Na HK, Surh YJ. Modulation of Nrf2-mediated antioxidant and
detoxifying enzyme induction by the green tea polyphenol
EGCG. Food Chem Toxicol. 2008;46:1271e1278.
20. Zelinski-Wooten MB, Slayden OD, Chwalisz K, et al. Chronic
treatment of female rhesus monkeys with low doses of the
antiprogestin ZK 137 316: establishment of a regimen that
permits normal menstrual cyclicity. Hum Reprod. 1998;13:
259e267.
21. Cameron ST, Critchley HO, Thong KJ, et al. Effects of daily low
dose mifepristone on endometrial maturation and prolifera-
tion. Hum Reprod. 1996;11:2518e2526.
22. Han S, Sidell N. RU486-induced growth inhibition of human
endometrial cells involves the nuclear factor-kappa B signaling
pathway. J Clin Endocrinol Metab. 2003;88:713e719.
23. Li A, Felix J, Minoo P, et al. Effect of mifepristone on prolif-
eration and apoptosis of Ishikawa endometrial adenocarcinoma
cells. Fertil Steril. 2005;84:202e211.
24. Moyer DL, Felix JC. The effects of progesterone and progestins
on endometrial proliferation. Contraception. 1998;57:
399e403.
25. Johnson MC, Maliqueo M, Boric MA, et al. Differential in vitro
actions of nitric oxide on human endometrial cell survival.
Fertil Steril. 2004;81:176e184.
26. Xu C, Shu WQ, Qiu ZQ, et al. Protective effects of green tea
polyphenols against subacute hepatotoxicity induced by
microcystin-LR in mice. Environ Toxicol Pharmacol. 2007;24:
140e148.
27. Guo S, Bezard E, Zhao B. Protective effect of green tea poly-
phenols on the SH-SY5Y cells against 6-OHDA induced apoptosis
through ROSeNO pathway. Free Radic Biol Med. 2005;39:
682e695.
28. Kim J, Formosa G, Li Y, et al. Epigallocatechin gallate, a green
tea polyphenol, mediates NO-dependent vasodilation using
signaling pathways in vascular endothelium requiring reactive
oxygen species and Fyn. J Biol Chem. 2007;282:13736e13745.
